Andrew Hull

Andrew Hull

Chairman presso INMED PHARMACEUTICALS INC.

Patrimonio netto: 13 926 $ in data 31/03/2024

61 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Andrew Hull is currently the Chairman at InMed Pharmaceuticals, Inc. He previously worked as the Director at the Illinois Biotechnology Industry Organization.
Additionally, he served as the Director at Zucara Therapeutics, Inc. from 2019 to 2020.
Mr. Hull was also a Trustee at Kenyon College.
Prior to that, he held the position of Vice President-Global Alliances at Takeda Pharmaceuticals U.S.A., Inc. from 2014 to 2018.
Hull completed his undergraduate degree at Kenyon College in 1985.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
21/02/2024 38 258 ( 0.63% ) 13 926 $ 31/03/2024

Posizioni attive di Andrew Hull

Precedenti posizioni note di Andrew Hull

SocietàPosizioneFine
Director/Board Member 01/03/2020
Corporate Officer/Principal 01/04/2018
Kenyon College Director/Board Member -
Chairman -
Vedi nel dettaglio l'esperienza di Andrew Hull

Formazione di Andrew Hull

Kenyon College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew Hull

Relazioni

85

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
INMED PHARMACEUTICALS INC.

Health Technology

Aziende private3

Health Technology

Commercial Services

Health Technology

Vedi le connessioni aziendali